Developer of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented. The company was founded in 2015 and headquartered in Wageningen, Netherlands. It has raised $5.9M in series a funding, with backing from Europa, Oost NL, Eurogenetic, Bridford Group, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Life Sciences Platforms and Tools, Food and Agriculture Tech - Crop Tech space. Its offerings span Genomics - Applied Genomics - Agrigenomics.
Hudson River Biotechnology
Series ADeveloper of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented. The company was founded…
About
Business model
Genomics > Applied Genomics > Agrigenomics,
Life Sciences Platforms and Tools > Research Services > Genomics,
Crop Tech > Farm Inputs > Plant Breeding > Technology Providers
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Full list of active funds — filter by stage, check size, and geography.
Similar startups
Raising like Hudson River Biotechnology?
Analyze your pitch deck before your next raise.
Analyze My Deck →